FDA flags most serious recall of Nova StatStrip Gen 2.0 hospital glucose meters

The study

This is not a research study. It is a safety notice from the US FDA (MedWatch), published in October 2026, about a recall by Nova Biomedical. The FDA has identified the recall as the most serious type. It says the device may cause serious injury or death if use continues.

The recall covers the StatStrip Glucose Hospital Meter System and the Glucose Hospital Meter System Multipack, in the newest "Gen 2.0" model. It does not apply to earlier models such as "Gen 1.86". Nova sent customers a first letter on July 31 and an updated letter on October 5.

What they found

Nova received customer reports of a display problem. When a patient ID or Quality Control (QC) barcode is scanned, earlier information can stay on the meter screen. If the user accepts it, the glucose result is assigned to the wrong patient's record or QC ID.

Nova says this affects Gen 2.0 meters on all firmware versions. It also says the analytical performance of the glucose measurement is not affected.

The FDA notice lists possible harms if the error is not noticed: delayed treatment, unnecessary treatment (including inappropriate insulin administration) and failure to treat the intended patient. The severity depends on the patient's actual glucose status and clinical condition. Critically ill patients and infants are at greater risk, because they may be unable to communicate symptoms of hypoglycaemia.

As of October 5, Nova reported one serious injury and no deaths. Nova has put a shipment hold on new Gen 2.0 meters. It plans a phased software update in November 2026.

Until then, Nova recommends these steps:

• If the EMR system includes integrated Admission, Discharge and Transfer (ADT) information, switch on "Validate Patient ID's" in NovaNet.
• Set the meters to log the operator out automatically after each test.
• After every barcode scan, check that the name, date of birth and other details on the Confirm Patient ID screen match the patient being tested, before pressing Accept.
• Check the patient ID again when the result appears. Do not assume it is unchanged since the scan.
• Report any wrongly assigned result to the administrator, and flag or remove it in the record so that others do not use it for glucose management.
• If an alternative device is available, stop using the affected meter.

How much weight to give it

This is a regulatory safety alert, so the usual study-design questions do not apply. The facts come from customer reports collected by the manufacturer. The notice does not say how many reports there were. It reports one serious injury. The statement that glucose measurement accuracy is not affected is the company's own.

The FDA's classification as the most serious recall type is a strong signal to act. The notice describes the risk as depending on whether the wrong ID goes unrecognised.

For your clinic

Hospitals and laboratories that use StatStrip meters should check which model they have. Gen 2.0 is affected. Gen 1.86 and earlier models are not.

The notice does not say whether affected meters are in use in India. Its contact details are for US customers. Hospital diabetes, ICU, neonatal and point-of-care testing teams may still wish to check their own devices and ask the supplier for guidance.

If Gen 2.0 meters are in use, the ID checks above are a process safeguard that teams can discuss with their point-of-care testing lead. If a result is found to be assigned to the wrong patient, the notice says it should be flagged or removed at once. The facility's usual procedures for correcting erroneous EMR entries should be followed, and the treating clinical team should be told promptly. Read the full FDA notice and Nova's customer advisory before changing any local procedure.